By Kim Stagliano
I am simply disgusted. Yesterday, Katie Wright told us yet again about outlandish behavior of members of the the Interagency Autism Coordinating Committee including Dr. Story Landis, Dr. Yvette Janvier, Dr. Matt State and Dr. Tom Insel. Aw heck, just click HERE to read all of Katie's posts. She's covered the IACC magnificently.
Earlier this month, we learned the autism numbers have risen yet again (HERE.) Autism now affects a staggering 1 in 91 children. 1 in 57 boys! A study pointed to the birth dose of Hepatitis B vaccine causing damage in infant primates, (HERE.) And that boys may have had a tripled rate of autism following Hepatitis B vaccination (HERE.) In short, vaccines were called into question again, even as the autism rates were continuing to climb. This puts the vaccine safety portion of the autism community squarely at odds with commerce. And that's a problem.
Last Spring, there was a webinar (click HERE) titled: "Vaccines: Is the Boom Sustainable in the Obama Era?" The title is self-explanatory. Despite the constant cry that vaccines are about altruistic public health and protecting the herd and doctors who selflessly administer medicine as if they are giving alms to the poor, vaccines make money. And now, ABC News has given us the answer about the "boom." (See below.)
The Obama adminstration's vaccine campaign choreography for the H1N1 flu has been nothing short of breathtaking. As in "I'm choking on it." Imagine if they could convince us all to buy American made cars with the same technique:
"Buy the new Gee-Um Dolt!
We need cars, America! There's a car scamdemic approaching fast and we can't get caught off guard. Save Gee-Um now! In order to get this car to market quickly, we've included an "older engine", even though we know that this engine was rumored to have had potential incendiary issues while driving. But it's cheaper and faster to build the Dolt with the Squinto engine. We didn't have much time to test the Dolt. However, six prototypes went four times around the 1 mile track and the smoke we saw wafting to the sky at the end of the trial wasn't directly coming from the engine, but was about half a mile behind the car, so we can't really say if the smoke came from the engine. The Dolt is safe! We are encouraging all Americans to drive a Dolt - again, to save Gee-Um motors. It's your civic duty! New York and New Jersey will not allow any car other than the Dolt to drive their toll roads or bridges."
Here's the article from ABC.
Drugmakers, Doctors Rake in Billions Battling H1N1 Flu.
Swine Flu Is Bad for Victims, But Good for Businesses That Cater to Expanding Market. Published on Wednesday, October 14, 2009 by ABC News by Dalia Fahmy
Americans are still debating whether to roll up their sleeves for a swine flu shot, but companies have already figured it out: vaccines are good for business.
Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market.
"The vaccine market is booming," says Bruce Carlson, spokesperson at market research firm Kalorama, which publishes an annual survey of the vaccine industry. "It's an enormous growth area for pharmaceuticals at a time when other areas are not doing so well," he says, noting that the pipeline for more traditional blockbuster drugs such as Lipitor and Nexium has thinned.
As always with pandemic flus, taxpayers are footing the $1.5 billion check for the 250 million swine flu vaccines that the government has ordered so far and will be distributing free to doctors, pharmacies and schools. In addition, Congress has set aside more than $10 billion this year to research flu viruses, monitor H1N1's progress and educate the public about prevention.
Drug makers pocket most of the revenues from flu sales, with Sanofi-Pasteur, Glaxo Smith Kline and Novartis cornering most of the market. But it's not just drug makers who stand to benefit. Doctors collect copays for injecting shots and use them to cover office expenses and insurance. Pharmacies also charge co-pays or full price of about $25 to those without insurance and often make more money if patients end up shopping for other goods..." Read the full article (HERE)
Kim Stagliano is Managing Editor of Age of Autism.